Abbott Laboratories

ABTNYSE • USD
108.52 USD
↗ 1.27 (1.18%)AT CLOSE (03:59 PM EST)
108.52
↘ 0.01 (0.00%)
POST MARKET (AS OF 08:14 PM EST)
Post Market
AS OF 08:14 PM EST
108.52
↘ 0.01 (0.00%)
🔴Market: CLOSED

ABT is currently priced at $108.52. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, ABT trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 13, 2026.

Open?$108.20
High?$109.28
Low?$107.03
Prev. Close?$107.25
Volume?6.2M
Avg. Volume?9.7M
VWAP?$108.58
Rel. Volume?0.64x
Bid / Ask
Bid?$107.53 × 100
Ask?$109.50 × 100
Spread?$1.97
Midpoint?$108.52
Valuation & Ratios
Market Cap?185.8B
Shares Out?1.7B
Float?1.7B
Float %?98.2%
P/E Ratio?39.51
P/B Ratio?3.64
EPS?$2.71
Dividend?2.33%
Ex-Dividend?N/A
News
Profile
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Employees
115.0K
Market Cap
185.8B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
1949-04-19
Address
100 ABBOTT PARK ROAD
ABBOTT PARK, IL 60064-3500
Phone: (224) 667-6100
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
80
Momentum?
48
Short Sent.?
79
Piotroski F-Score?4/9Mixed
Altman Z-Score?3.34Safe
Confidence?73%Moderate
Full Fundamental Analysis →
Short Interest
Loading...
Financial Health
Current Ratio?1.45Adequate
Quick Ratio?1.00Adequate
Cash Ratio?0.25Low
Debt/Equity?0.61Moderate
ValuationFAIRLY VALUEDvs 10 peers + S&P 500
Score
56/100
P/E?
Peers
55
S&P
18
39.5PRICEY▾
P/B?
Peers
50
S&P
48
3.64FAIR▾
P/S?
Peers
55
S&P
39
3.85FAIR▾
P/FCF?
Peers
64
S&P
34
27.5FAIR▾
EV/EBITDA?
Peers
45
S&P
25
20.2HIGH▾
EV/Sales?
Peers
55
S&P
41
4.41FAIR▾
Returns & Efficiency
ROE?
Peers
30
S&P
31
9.2%FAIR▾
ROA?
Peers
36
S&P
40
4.3%FAIR▾
Cash Flow & Enterprise
FCF?$6.8B
Enterprise Value?$212.9B
Fundamentals ratios updated end of day